Loading...

PE Streptavidin PE Streptavidin

Pricing & Availability
Regulatory Status
RUO
Other Names
Streptavidin-Phycoerythrin, SAv-PE
Ave. Rating
Submit a Review
Product Citations
publications
SAV_PE_082808.jpg
C57BL/6 splenocytes stained with 145-2C11 biotin, followed by SAV-PE
  • SAV_PE_082808.jpg
    C57BL/6 splenocytes stained with 145-2C11 biotin, followed by SAV-PE
See PE spectral data
Cat # Size Price Quantity Check Availability Save
405203 100 µg DKK333
Check Availability


Need larger quantities of this item?
Request Bulk Quote
405204 500 µg DKK1159
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

Streptavidin binds to biotin with high affinity. Streptavidin-Phycoerythrin (PE) is useful for detecting biotinylated antibodies. The excitation of PE by 488 nm laser light induces a light emission maximum of 575 nm.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Human, Mouse, Rat, All Species
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
Streptavidin is conjugated with PE under optimal conditions.
Concentration
0.2 mg/ml (concentration relates to the Streptavidin only component of the conjugate)
Storage & Handling
The streptavidin-PE solution should be stored undiluted between 2°C and 8°C, and protected from exposure to light. Do not freeze.
Application

FC - Quality tested

ICFC - Verified
Recommended Usage

This streptavidin product is quality control tested by immunofluorescent staining with flow cytometric analysis. The concentration provided is based upon molecular mass of streptavidin independent of any additional molecular mass that might be added by the PE conjugation. For flow cytometric staining, the suggested use of this reagent is ≤0.06 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Green Laser (532 nm)/Yellow-Green Laser (561 nm)
Application Notes

Streptavidin-Phycoerythrin (PE) is useful as a second step reagent for indirect immunofluorescent staining, when used in conjunction with biotinylated primary antibodies. The average molecular weight of Streptavidin-PE is 360 kD and Streptavidin alone is 52 kD.

Application References
  1. Chappaz S, et al. 2007. Blood doi:10.1182/blood-2007-02-074245.
  2. Nishimoto KP,et al. 2008. J. Immunol. 181:4010.PubMed
  3. Niki T, et al. 2009. J. Biol. Chem. 284:32344. PubMed
  4. Shibui A, et al. 2011. Exp Parasitol. 129:318. PubMed
  5. Scatizzi JC, et al. 2012. J. Immunol. 188:3307. PubMed
  6. Yamakawa N, et al. 2012. Int Immunol. 25:45. PubMed
  7. Shibata T, et al. 2012. Int Immunol. 24:613. PubMed
  8. Baccala R, et al. 2012. J. Immunol. 189:5976. PubMed
  9. Grevers LC, et al. 2013. Ann Reheum Dis. 72:278. PubMed
  10. Woo SJ, et al. 2013. J Leukoc Biol. 93:363. PubMed
  11. Ashbaugh JJ, et al. 2013. J. Immunol. 190:4525. PubMed
  12. Reading JL, 2013. J. immunol. 190:4542. Pubmed.
  13. Kanno A, et al. 2013. Int Immunol. 25:413. PubMed
  14. Gunaydin G, et al. 2014. Vaccine. 32:470. PubMed
  15. Lyngaa R, et al. 2014. Clin Cancer Res. 20:1768. PubMed
  16. Datta S, et al. 2014. J Leukoc Biol. 95:853. PubMed
  17. He X, et al. 2014. J Immunol. 193:1314. PubMed
  18. Wang W, et al. 2014. PNAS. 111:14466. PubMed
  19. Murakami Y, et al. 2014. J Immunol. 193:5208. PubMed
  20. Lucas A, et al. 2015. PLoS One. 10:117160. PubMed
  21. Kim Yu, et al. 2015. PLoS One. 10:120294. PubMed
  22. Hua X, et al. 2015. PloS One. 10:128039. PubMed
Product Citations
  1. Eger C, et al. 2016. PLoS One. 11: 0150479. PubMed
  2. Yang J, et al. 2016. Sci Rep. 6:38238. PubMed
  3. Chen T, et al. 2016. J Exp Med. 13(13):3025-3039. PubMed
  4. Martínez-Blanco Á, et al. 2021. Front Immunol. 12:713697. PubMed
  5. Wang H, et al. 2020. Mol Oncol. 14:991. PubMed
  6. Zhang Y, et al. 2017. Journal of Immunological Methods. 10.1016/j.taap.2017.05.020. PubMed
  7. Wu Y, et al. 2021. Immunity. 54:2595. PubMed
  8. Goel RR, et al. 2022. Cell. 185:1875. PubMed
  9. Campisi L, et al. 2022. Nature. 606:945. PubMed
  10. Grégoire C, et al. 2022. Immunity. 55:1216. PubMed
  11. Wu Y, et al. 2022. Sci Adv. 8:eabm7833. PubMed
  12. Cao Y, et al. 2023. Nature. 614:521. PubMed
  13. Weskamm LM, et al. 2022. STAR Protoc. 3:101902. PubMed
  14. Mekkaoui L, et al. 2023. Mol Ther Methods Clin Dev. 28:116. PubMed
  15. Lombard-Vadnais F, et al. 2023. iScience. 26:105852. PubMed
  16. Hernandez SPA, et al. 2023. Front Immunol. 13:1035344. PubMed
  17. Pušnik J, et al. 2023. Nat Commun. 14:572. PubMed
  18. Knyphausen P, et al. 2023. Nat Commun. 14:768. PubMed
  19. Yeh CH, et al. 2022. Immunity. 55:272. PubMed
  20. Feng J, et al. 2022. Immunity. 55:405. PubMed
  21. Tas JMJ, et al. 2022. Immunity. 55:1856. PubMed
  22. Melzi E, et al. 2022. Immunity. 55:2168. PubMed
  23. Vyasamneni R, et al. 2023. Cell Rep Methods. 3:100388. PubMed
  24. Ke F, et al. 2023. Elife. 12:. PubMed
  25. Li D, et al. 2023. Int J Oncol. 62:. PubMed
  26. Silva RP, et al. 2023. Elife. 12:. PubMed
  27. Nozuma S, et al. 2023. JCI Insight. 8:. PubMed
  28. García-Vega M, et al. 2023. iScience. 26:106562. PubMed
  29. Liu Y, et al. 2023. Nat Commun. 14:2179. PubMed
  30. Fathi M, et al. 2023. iScience. 26:106482. PubMed
  31. Xiao C, et al. 2023. Nat Aging. 3:418. PubMed
  32. Lv X, et al. 2023. Acta Pharm Sin B. 13:1631. PubMed
  33. Li X, et al. 2023. Nat Commun. 14:2929. PubMed
  34. Tundidor I, et al. 2023. Nat Commun. 14:3130. PubMed
  35. Chen K, et al. 2023. Gut Pathog. 15:28. PubMed
  36. Golubovskaya V, et al. 2023. Cancers (Basel). 15:. PubMed
  37. Tian L, et al. 2021. Int J Mol Sci. 22: . PubMed
  38. Lv X, et al. 2022. Acta Pharm Sin B. 12:735. PubMed
  39. Muliaditan T, et al. 2021. Cell Rep Med. 2:100457. PubMed
  40. Datta S, et al. 2014. J Leukoc Biol. 95:853. PubMed
  41. Larsen SB, et al. 2021. Cell Stem Cell. 28:1758. PubMed
  42. Delás MJ, et al. 2019. Cell Rep. 27:719. PubMed
  43. Viborg N, et al. 2019. Oncoimmunology. 8:e1663107. PubMed
  44. Yamakawa N, et al. 2012. Int Immunol. 25:45. PubMed
  45. Grevers L, et al. 2013. Ann Rheum Dis. 72:278. PubMed
  46. Gatineau J, et al. 2022. Front Immunol. 13:982839. PubMed
  47. Trendel N, et al. 2021. Sci Signal. 14:eaay9363. PubMed
  48. Biswas S, et al. 2021. Nature. 591:464. PubMed
  49. Wellner A, et al. 2021. Nat Chem Biol. 17:1057. PubMed
  50. Gniffke EP, et al. 2020. medRxiv. . PubMed
  51. Ruiz–Camp J, et al. 2019. EMBO Mol Med. 11:3. PubMed
  52. Nie X, et al. 2017. Cellular & Molecular Immunology. 10.1038/cmi.2017.17. PubMed
  53. Hernandez-Franco JF, et al. 2022. Front Immunol. 13:990900. PubMed
  54. Liang Q, et al. 2022. iScience. 25:104043. PubMed
  55. Xiao C, et al. 2022. iScience. 25:103934. PubMed
  56. Imbrechts M, et al. 2022. iScience. 25:104705. PubMed
  57. Kim Y, et al. 2015. PLoS One. 10:120294. PubMed
  58. Yamamoto K, et al. 2021. Cell Reports. 36(8):109576. PubMed
  59. Fukushima T, et al. 2019. Cell Rep. 29:4144. PubMed
  60. Ashbaugh J, et al. 2013. J Immunol. 190:4525. PubMed
  61. Hayatsu N et al. 2017. Immunity. 47(2):268-283 . PubMed
  62. Hu Y, et al. 2022. Nat Commun. 13:5313. PubMed
  63. Im S, et al. 2016. Nature. 537:417-421. PubMed
  64. He X, et al. 2021. Emerg Microbes Infect. 10:1555. PubMed
  65. Nishimoto K, et al. 2008. J Immunol. 181:4010. PubMed
  66. Cao Y, et al. 2022. Nature. :. PubMed
  67. Tsukamoto H, et al. 2013. Biochem Biophys Res Commun. 440:31. PubMed
  68. Phiwpan K, et al. 2015. PLoS One. 10:128198. PubMed
  69. Weiß S, et al. 2020. J Infect Dis. 222:1629. PubMed
  70. Schanda N, et al. 2021. Cells. 10:. PubMed
  71. Lucas A, et al. 2015. PLoS One. 10:117160. PubMed
  72. Köchl R, et al. 2020. Elife. 9:00. PubMed
  73. Niki T, et al. 2009. J Biol Chem. 284:32344. PubMed
  74. Ping Y, et al. 2020. Front Cell Dev Biol. 0.890972222. PubMed
  75. Lv Z, et al. 2020. Oncoimmunology. 9:1747688. PubMed
  76. Pfenninger P, et al. 2022. Front Immunol. 13:777113. PubMed
  77. Kristensen NP, et al. 2022. J Clin Invest. 132:. PubMed
  78. Qiu C, et al. 2022. Front Immunol. 12:764949. PubMed
  79. Cao Y, et al. 2022. Nature. 602:657. PubMed
  80. Rogers BM, et al. 2021. J Exp Med. 218:. PubMed
  81. Weiß S, et al. 2020. medRxiv. . PubMed
  82. Morimoto A, et al. 2021. Nat Commun. 12:2136. PubMed
  83. Kim C, et al. 2019. Cell Rep. 29:2202. PubMed
  84. Hansen UK, et al. 2020. Front Immunol. 11:373. PubMed
  85. Reading J, et al. 2013. J Immunol. 190:4542. PubMed
  86. Dietmar Herndler‐Brandstetter et al. 2018. Immunity. 48(4):716-729 . PubMed
  87. Mei H, et al. 2021. J Hematol Oncol. 14:161. PubMed
  88. Repáraz D, et al. 2022. J Immunother Cancer. 10:. PubMed
  89. Tschismarov R, et al. 2021. JCI Insight. 6:. PubMed
  90. Richardson LS, et al. 2020. Lab Chip. 3.948611111. PubMed
  91. Hebbar N, et al. 2022. Nat Commun. 13:587. PubMed
  92. McWilliam H, et al. 2016. Nat Immunol. 17: 531-537. PubMed
  93. Zhang S, et al. 2016. Sci Transl Med. 8: 341ra77. PubMed
  94. Kacherovsky N, et al. 2019. Nat Biomed Eng. 0.66875. PubMed
  95. Van Gool F, et al. 2019. Immunity. 50:362. PubMed
  96. Mainini F, et al. 2015. PLoS One. 10: 0145403. PubMed
  97. Jiang Y, et al. 2021. Cell Death Differ. 28:3009. PubMed
  98. Woo S, et al. 2013. J Leukoc Biol. 93:363. PubMed
  99. Baccala R, et al. 2012. J Immunol. 189:5976. PubMed
  100. Delacher M, et al. 2020. Immunity. 52:295. PubMed
  101. Tsukamoto H, et al. 2017. FEBS Lett. 10.1002/1873-3468.12768. PubMed
  102. Parente-Pereira AC, et al. 2022. STAR Protoc. 3:101319. PubMed
  103. Baltierra-Uribe SL, et al. 2021. Eur J Immunol. 51:2641. PubMed
  104. Schoutrop E, et al. 2022. Oncoimmunology. 11:2093426. PubMed
  105. Günaydın G, et al. 2014. Vaccine. 32:470. PubMed
  106. Matt P, et al. 2015. PLoS One. 10: 0137474. PubMed
  107. Davis Z, et al. 2016. PLoS Pathog. 12: 1005421. PubMed
  108. Roewe J, et al. 2020. Nat Commun. 3.260416667. PubMed
  109. Carestia A, et al. 2019. Cell Rep. 28:896. PubMed
  110. Scatizzi J, et al. 2012. J Immunol. 188:3307. PubMed
  111. Tian B, et al. 2017. Front Immunol. 10.3389/fimmu.2017.00956. PubMed
  112. Schoofs T et al. 2019. Immunity. 50(6):1513-1529 . PubMed
  113. Guo C, et al. 2021. Cell Rep Med. 2:100448. PubMed
  114. Chen YL, et al. 2021. J Biol Chem. :101420. PubMed
  115. Zhong MC, et al. 2021. J Exp Med. 218:. PubMed
  116. Mudd PA, et al. 2022. Cell. 185:603. PubMed
  117. Morikawa M, et al. 2016. PLoS One. 11:e0163607. PubMed
  118. Gniffke EP, et al. 2020. J Infect Dis. 222:1965. PubMed
  119. Leung EYL, et al. 2020. Mol Ther Oncolytics. 16:289. PubMed
  120. Nowak W, et al. 2020. EBioMedicine. 50:290-305.. PubMed
  121. Matsuda T, et al. 2022. iScience. 25:105324. PubMed
  122. Kim SP, et al. 2022. Cancer Immunol Res. :OF1. PubMed
  123. Cheloha RW, et al. 2021. RSC chem biol. 2:1692. PubMed
  124. Okamoto Y, et al. 2021. J Cell Sci. 134:. PubMed
  125. Wang W, et al. 2014. Proc Natl Acad Sci U S A. 111:14466. PubMed
  126. Miyauchi K, et al. 2016. Nat Immunol. 17:1447-1458. PubMed
  127. Hoffmann J, et al. 2021. Nat Commun. 12:3964. PubMed
  128. Lu X, et al. 2019. Cell Rep. 28:472. PubMed
  129. Andersen TK, et al. 2019. NPJ Vaccines. 4:9. PubMed
  130. He X, et al. 2014. J Immunol. 193:1314. PubMed
  131. Kanno A, et al. 2013. Int Immunol. 25:413. PubMed
  132. Dan JM, et al. 2021. Science. :371. PubMed
  133. Leary N, et al. 2022. J Extracell Vesicles. 11:e12197. PubMed
  134. Murakami Y, et al. 2014. J Immunol. 193:5208. PubMed
  135. Mchedlidze T, et al. 2016. Mucosal Immunol. 10.1038/mi.2016.20. PubMed
  136. Walker MR, et al. 2022. Sci Adv. 8:eabj9513. PubMed
  137. Yang Zhou J, et al. 2022. Front Immunol. 13:898473. PubMed
  138. Deng J, et al. 2021. J Leukoc Biol. 110:1171. PubMed
  139. DanDan Huang, Lang Bao 2016. J Microbiol Immunol Infect. 49:859-865. PubMed
  140. Kurashima Y, et al. 2021. Nat Commun. 12:1067. PubMed
  141. Wells DK, et al. 2020. Cell. 183:818. PubMed
  142. Schürch CM, et al. 2020. Cell. 182:1341. PubMed
  143. Chappaz S, et al. 2010. J Immunol. 185:3514. PubMed
  144. Altman JB, et al. 2018. Health Sci Rep. 1:e74. PubMed
  145. Hirunwidchayarat W, et al. 2017. Biochem Biophys Res Commun. 10.1016/j.bbrc.2017.07.012. PubMed
  146. Wang EY, et al. 2022. Cell Rep Methods. 2:. PubMed
  147. Lyngaa R, et al. 2014. Clin Cancer Res. 20:1768. PubMed
  148. Tripathi S, et al. 2016. Proc Natl Acad Sci U S A. 113: 1555 - 1564. PubMed
  149. Ando Y, Oku T, Tsuji T 2016. PLoS One. 11: 0162208. PubMed
  150. Zheng Q, et al. 2017. Mol Oncol. 10.1002/1878-0261.12056. PubMed
  151. Pedersen NW, et al. 2019. Nat Commun. 10:837. PubMed
  152. Yang C, et al. 2019. Nat Commun. 10:3931. PubMed
  153. Xiao C, et al. 2021. STAR Protoc. 2:100789. PubMed
  154. Rodrigues KA, et al. 2021. Sci Adv. 7:eabj6538. PubMed
  155. Szeto C, et al. 2022. Nat Commun. 13:4951. PubMed
  156. Yoshikawa S, et al. 2016. Sci Rep. 6:18738. PubMed
  157. Shibui A, et al. 2011. Exp Parasitol. 129:318. PubMed
  158. Wirasinha RC, et al. 2021. J Exp Med. 218: . PubMed
  159. Du Z, et al. 2020. J Allergy Clin Immunol. . PubMed
  160. Lautz JD, et al. 2019. Sci Rep. 9:10890. PubMed
  161. Kenney M, et al. 2017. Journal of Immunological Methods. 10.1016/j.jim.2017.07.001. PubMed
  162. Holm JS, et al. 2022. Nat Commun. 13:1935. PubMed
  163. Eger C, et al. 2016. PLoS One. 11: 0150479. PubMed
  164. Yang J, et al. 2016. Sci Rep. 6:38238. PubMed
  165. Chen T, et al. 2016. J Exp Med. 13(13):3025-3039. PubMed
  166. Martínez-Blanco Á, et al. 2021. Front Immunol. 12:713697. PubMed
  167. Wang H, et al. 2020. Mol Oncol. 14:991. PubMed
  168. Zhang Y, et al. 2017. Journal of Immunological Methods. 10.1016/j.taap.2017.05.020. PubMed
  169. Wu Y, et al. 2021. Immunity. 54:2595. PubMed
  170. Goel RR, et al. 2022. Cell. 185:1875. PubMed
  171. Campisi L, et al. 2022. Nature. 606:945. PubMed
  172. Grégoire C, et al. 2022. Immunity. 55:1216. PubMed
  173. Wu Y, et al. 2022. Sci Adv. 8:eabm7833. PubMed
  174. Cao Y, et al. 2023. Nature. 614:521. PubMed
  175. Weskamm LM, et al. 2022. STAR Protoc. 3:101902. PubMed
  176. Mekkaoui L, et al. 2023. Mol Ther Methods Clin Dev. 28:116. PubMed
  177. Lombard-Vadnais F, et al. 2023. iScience. 26:105852. PubMed
  178. Hernandez SPA, et al. 2023. Front Immunol. 13:1035344. PubMed
  179. Pušnik J, et al. 2023. Nat Commun. 14:572. PubMed
  180. Knyphausen P, et al. 2023. Nat Commun. 14:768. PubMed
  181. Yeh CH, et al. 2022. Immunity. 55:272. PubMed
  182. Feng J, et al. 2022. Immunity. 55:405. PubMed
  183. Tas JMJ, et al. 2022. Immunity. 55:1856. PubMed
  184. Melzi E, et al. 2022. Immunity. 55:2168. PubMed
  185. Vyasamneni R, et al. 2023. Cell Rep Methods. 3:100388. PubMed
  186. Ke F, et al. 2023. Elife. 12:. PubMed
  187. Li D, et al. 2023. Int J Oncol. 62:. PubMed
  188. Silva RP, et al. 2023. Elife. 12:. PubMed
  189. Nozuma S, et al. 2023. JCI Insight. 8:. PubMed
  190. García-Vega M, et al. 2023. iScience. 26:106562. PubMed
  191. Liu Y, et al. 2023. Nat Commun. 14:2179. PubMed
  192. Fathi M, et al. 2023. iScience. 26:106482. PubMed
  193. Xiao C, et al. 2023. Nat Aging. 3:418. PubMed
  194. Lv X, et al. 2023. Acta Pharm Sin B. 13:1631. PubMed
  195. Li X, et al. 2023. Nat Commun. 14:2929. PubMed
  196. Tundidor I, et al. 2023. Nat Commun. 14:3130. PubMed
  197. Chen K, et al. 2023. Gut Pathog. 15:28. PubMed
  198. Golubovskaya V, et al. 2023. Cancers (Basel). 15:. PubMed
  199. Tian L, et al. 2021. Int J Mol Sci. 22: . PubMed
  200. Lv X, et al. 2022. Acta Pharm Sin B. 12:735. PubMed
  201. Muliaditan T, et al. 2021. Cell Rep Med. 2:100457. PubMed
  202. Datta S, et al. 2014. J Leukoc Biol. 95:853. PubMed
  203. Larsen SB, et al. 2021. Cell Stem Cell. 28:1758. PubMed
  204. Delás MJ, et al. 2019. Cell Rep. 27:719. PubMed
  205. Viborg N, et al. 2019. Oncoimmunology. 8:e1663107. PubMed
  206. Yamakawa N, et al. 2012. Int Immunol. 25:45. PubMed
  207. Grevers L, et al. 2013. Ann Rheum Dis. 72:278. PubMed
  208. Gatineau J, et al. 2022. Front Immunol. 13:982839. PubMed
  209. Trendel N, et al. 2021. Sci Signal. 14:eaay9363. PubMed
  210. Biswas S, et al. 2021. Nature. 591:464. PubMed
  211. Wellner A, et al. 2021. Nat Chem Biol. 17:1057. PubMed
  212. Gniffke EP, et al. 2020. medRxiv. . PubMed
  213. Ruiz–Camp J, et al. 2019. EMBO Mol Med. 11:3. PubMed
  214. Nie X, et al. 2017. Cellular & Molecular Immunology. 10.1038/cmi.2017.17. PubMed
  215. Hernandez-Franco JF, et al. 2022. Front Immunol. 13:990900. PubMed
  216. Liang Q, et al. 2022. iScience. 25:104043. PubMed
  217. Xiao C, et al. 2022. iScience. 25:103934. PubMed
  218. Imbrechts M, et al. 2022. iScience. 25:104705. PubMed
  219. Kim Y, et al. 2015. PLoS One. 10:120294. PubMed
  220. Yamamoto K, et al. 2021. Cell Reports. 36(8):109576. PubMed
  221. Fukushima T, et al. 2019. Cell Rep. 29:4144. PubMed
  222. Ashbaugh J, et al. 2013. J Immunol. 190:4525. PubMed
  223. Hayatsu N et al. 2017. Immunity. 47(2):268-283 . PubMed
  224. Hu Y, et al. 2022. Nat Commun. 13:5313. PubMed
  225. Im S, et al. 2016. Nature. 537:417-421. PubMed
  226. He X, et al. 2021. Emerg Microbes Infect. 10:1555. PubMed
  227. Nishimoto K, et al. 2008. J Immunol. 181:4010. PubMed
  228. Cao Y, et al. 2022. Nature. :. PubMed
  229. Tsukamoto H, et al. 2013. Biochem Biophys Res Commun. 440:31. PubMed
  230. Phiwpan K, et al. 2015. PLoS One. 10:128198. PubMed
  231. Weiß S, et al. 2020. J Infect Dis. 222:1629. PubMed
  232. Schanda N, et al. 2021. Cells. 10:. PubMed
  233. Lucas A, et al. 2015. PLoS One. 10:117160. PubMed
  234. Köchl R, et al. 2020. Elife. 9:00. PubMed
  235. Niki T, et al. 2009. J Biol Chem. 284:32344. PubMed
  236. Ping Y, et al. 2020. Front Cell Dev Biol. 0.890972222. PubMed
  237. Lv Z, et al. 2020. Oncoimmunology. 9:1747688. PubMed
  238. Pfenninger P, et al. 2022. Front Immunol. 13:777113. PubMed
  239. Kristensen NP, et al. 2022. J Clin Invest. 132:. PubMed
  240. Qiu C, et al. 2022. Front Immunol. 12:764949. PubMed
  241. Cao Y, et al. 2022. Nature. 602:657. PubMed
  242. Rogers BM, et al. 2021. J Exp Med. 218:. PubMed
  243. Weiß S, et al. 2020. medRxiv. . PubMed
  244. Morimoto A, et al. 2021. Nat Commun. 12:2136. PubMed
  245. Kim C, et al. 2019. Cell Rep. 29:2202. PubMed
  246. Hansen UK, et al. 2020. Front Immunol. 11:373. PubMed
  247. Reading J, et al. 2013. J Immunol. 190:4542. PubMed
  248. Dietmar Herndler‐Brandstetter et al. 2018. Immunity. 48(4):716-729 . PubMed
  249. Mei H, et al. 2021. J Hematol Oncol. 14:161. PubMed
  250. Repáraz D, et al. 2022. J Immunother Cancer. 10:. PubMed
  251. Tschismarov R, et al. 2021. JCI Insight. 6:. PubMed
  252. Richardson LS, et al. 2020. Lab Chip. 3.948611111. PubMed
  253. Hebbar N, et al. 2022. Nat Commun. 13:587. PubMed
  254. McWilliam H, et al. 2016. Nat Immunol. 17: 531-537. PubMed
  255. Zhang S, et al. 2016. Sci Transl Med. 8: 341ra77. PubMed
  256. Kacherovsky N, et al. 2019. Nat Biomed Eng. 0.66875. PubMed
  257. Van Gool F, et al. 2019. Immunity. 50:362. PubMed
  258. Mainini F, et al. 2015. PLoS One. 10: 0145403. PubMed
  259. Jiang Y, et al. 2021. Cell Death Differ. 28:3009. PubMed
  260. Woo S, et al. 2013. J Leukoc Biol. 93:363. PubMed
  261. Baccala R, et al. 2012. J Immunol. 189:5976. PubMed
  262. Delacher M, et al. 2020. Immunity. 52:295. PubMed
  263. Tsukamoto H, et al. 2017. FEBS Lett. 10.1002/1873-3468.12768. PubMed
  264. Parente-Pereira AC, et al. 2022. STAR Protoc. 3:101319. PubMed
  265. Baltierra-Uribe SL, et al. 2021. Eur J Immunol. 51:2641. PubMed
  266. Schoutrop E, et al. 2022. Oncoimmunology. 11:2093426. PubMed
  267. Günaydın G, et al. 2014. Vaccine. 32:470. PubMed
  268. Matt P, et al. 2015. PLoS One. 10: 0137474. PubMed
  269. Davis Z, et al. 2016. PLoS Pathog. 12: 1005421. PubMed
  270. Roewe J, et al. 2020. Nat Commun. 3.260416667. PubMed
  271. Carestia A, et al. 2019. Cell Rep. 28:896. PubMed
  272. Scatizzi J, et al. 2012. J Immunol. 188:3307. PubMed
  273. Tian B, et al. 2017. Front Immunol. 10.3389/fimmu.2017.00956. PubMed
  274. Schoofs T et al. 2019. Immunity. 50(6):1513-1529 . PubMed
  275. Guo C, et al. 2021. Cell Rep Med. 2:100448. PubMed
  276. Chen YL, et al. 2021. J Biol Chem. :101420. PubMed
  277. Zhong MC, et al. 2021. J Exp Med. 218:. PubMed
  278. Mudd PA, et al. 2022. Cell. 185:603. PubMed
  279. Morikawa M, et al. 2016. PLoS One. 11:e0163607. PubMed
  280. Gniffke EP, et al. 2020. J Infect Dis. 222:1965. PubMed
  281. Leung EYL, et al. 2020. Mol Ther Oncolytics. 16:289. PubMed
  282. Nowak W, et al. 2020. EBioMedicine. 50:290-305.. PubMed
  283. Matsuda T, et al. 2022. iScience. 25:105324. PubMed
  284. Kim SP, et al. 2022. Cancer Immunol Res. :OF1. PubMed
  285. Cheloha RW, et al. 2021. RSC chem biol. 2:1692. PubMed
  286. Okamoto Y, et al. 2021. J Cell Sci. 134:. PubMed
  287. Wang W, et al. 2014. Proc Natl Acad Sci U S A. 111:14466. PubMed
  288. Miyauchi K, et al. 2016. Nat Immunol. 17:1447-1458. PubMed
  289. Hoffmann J, et al. 2021. Nat Commun. 12:3964. PubMed
  290. Lu X, et al. 2019. Cell Rep. 28:472. PubMed
  291. Andersen TK, et al. 2019. NPJ Vaccines. 4:9. PubMed
  292. He X, et al. 2014. J Immunol. 193:1314. PubMed
  293. Kanno A, et al. 2013. Int Immunol. 25:413. PubMed
  294. Dan JM, et al. 2021. Science. :371. PubMed
  295. Leary N, et al. 2022. J Extracell Vesicles. 11:e12197. PubMed
  296. Murakami Y, et al. 2014. J Immunol. 193:5208. PubMed
  297. Mchedlidze T, et al. 2016. Mucosal Immunol. 10.1038/mi.2016.20. PubMed
  298. Walker MR, et al. 2022. Sci Adv. 8:eabj9513. PubMed
  299. Yang Zhou J, et al. 2022. Front Immunol. 13:898473. PubMed
  300. Deng J, et al. 2021. J Leukoc Biol. 110:1171. PubMed
  301. DanDan Huang, Lang Bao 2016. J Microbiol Immunol Infect. 49:859-865. PubMed
  302. Kurashima Y, et al. 2021. Nat Commun. 12:1067. PubMed
  303. Wells DK, et al. 2020. Cell. 183:818. PubMed
  304. Schürch CM, et al. 2020. Cell. 182:1341. PubMed
  305. Chappaz S, et al. 2010. J Immunol. 185:3514. PubMed
  306. Altman JB, et al. 2018. Health Sci Rep. 1:e74. PubMed
  307. Hirunwidchayarat W, et al. 2017. Biochem Biophys Res Commun. 10.1016/j.bbrc.2017.07.012. PubMed
  308. Wang EY, et al. 2022. Cell Rep Methods. 2:. PubMed
  309. Lyngaa R, et al. 2014. Clin Cancer Res. 20:1768. PubMed
  310. Tripathi S, et al. 2016. Proc Natl Acad Sci U S A. 113: 1555 - 1564. PubMed
  311. Ando Y, Oku T, Tsuji T 2016. PLoS One. 11: 0162208. PubMed
  312. Zheng Q, et al. 2017. Mol Oncol. 10.1002/1878-0261.12056. PubMed
  313. Pedersen NW, et al. 2019. Nat Commun. 10:837. PubMed
  314. Yang C, et al. 2019. Nat Commun. 10:3931. PubMed
  315. Xiao C, et al. 2021. STAR Protoc. 2:100789. PubMed
  316. Rodrigues KA, et al. 2021. Sci Adv. 7:eabj6538. PubMed
  317. Szeto C, et al. 2022. Nat Commun. 13:4951. PubMed
  318. Yoshikawa S, et al. 2016. Sci Rep. 6:18738. PubMed
  319. Shibui A, et al. 2011. Exp Parasitol. 129:318. PubMed
  320. Wirasinha RC, et al. 2021. J Exp Med. 218: . PubMed
  321. Du Z, et al. 2020. J Allergy Clin Immunol. . PubMed
  322. Lautz JD, et al. 2019. Sci Rep. 9:10890. PubMed
  323. Kenney M, et al. 2017. Journal of Immunological Methods. 10.1016/j.jim.2017.07.001. PubMed
  324. Holm JS, et al. 2022. Nat Commun. 13:1935. PubMed

Related FAQs

What type of PE do you use in your conjugates?
We use R-PE in our conjugates.
Go To Top Version: 6    Revision Date: 06/17/2019

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

Pricing & Availability
Regulatory Status
RUO
Other Names
Streptavidin-Phycoerythrin, SAv-PE
Ave. Rating
Submit a Review
Product Citations
publications
SAV_PE_082808.jpg
C57BL/6 splenocytes stained with 145-2C11 biotin, followed by SAV-PE
  • SAV_PE_082808.jpg
    C57BL/6 splenocytes stained with 145-2C11 biotin, followed by SAV-PE
See PE spectral data
Cat # Size Price Quantity Check Availability Save
405203 100 µg DKK333
Check Availability


Need larger quantities of this item?
Request Bulk Quote
405204 500 µg DKK1159
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

Streptavidin binds to biotin with high affinity. Streptavidin-Phycoerythrin (PE) is useful for detecting biotinylated antibodies. The excitation of PE by 488 nm laser light induces a light emission maximum of 575 nm.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Human, Mouse, Rat, All Species
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
Streptavidin is conjugated with PE under optimal conditions.
Concentration
0.2 mg/ml (concentration relates to the Streptavidin only component of the conjugate)
Storage & Handling
The streptavidin-PE solution should be stored undiluted between 2°C and 8°C, and protected from exposure to light. Do not freeze.
Application

FC - Quality tested

ICFC - Verified
Recommended Usage

This streptavidin product is quality control tested by immunofluorescent staining with flow cytometric analysis. The concentration provided is based upon molecular mass of streptavidin independent of any additional molecular mass that might be added by the PE conjugation. For flow cytometric staining, the suggested use of this reagent is ≤0.06 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Green Laser (532 nm)/Yellow-Green Laser (561 nm)
Application Notes

Streptavidin-Phycoerythrin (PE) is useful as a second step reagent for indirect immunofluorescent staining, when used in conjunction with biotinylated primary antibodies. The average molecular weight of Streptavidin-PE is 360 kD and Streptavidin alone is 52 kD.

Application References
  1. Chappaz S, et al. 2007. Blood doi:10.1182/blood-2007-02-074245.
  2. Nishimoto KP,et al. 2008. J. Immunol. 181:4010.PubMed
  3. Niki T, et al. 2009. J. Biol. Chem. 284:32344. PubMed
  4. Shibui A, et al. 2011. Exp Parasitol. 129:318. PubMed
  5. Scatizzi JC, et al. 2012. J. Immunol. 188:3307. PubMed
  6. Yamakawa N, et al. 2012. Int Immunol. 25:45. PubMed
  7. Shibata T, et al. 2012. Int Immunol. 24:613. PubMed
  8. Baccala R, et al. 2012. J. Immunol. 189:5976. PubMed
  9. Grevers LC, et al. 2013. Ann Reheum Dis. 72:278. PubMed
  10. Woo SJ, et al. 2013. J Leukoc Biol. 93:363. PubMed
  11. Ashbaugh JJ, et al. 2013. J. Immunol. 190:4525. PubMed
  12. Reading JL, 2013. J. immunol. 190:4542. Pubmed.
  13. Kanno A, et al. 2013. Int Immunol. 25:413. PubMed
  14. Gunaydin G, et al. 2014. Vaccine. 32:470. PubMed
  15. Lyngaa R, et al. 2014. Clin Cancer Res. 20:1768. PubMed
  16. Datta S, et al. 2014. J Leukoc Biol. 95:853. PubMed
  17. He X, et al. 2014. J Immunol. 193:1314. PubMed
  18. Wang W, et al. 2014. PNAS. 111:14466. PubMed
  19. Murakami Y, et al. 2014. J Immunol. 193:5208. PubMed
  20. Lucas A, et al. 2015. PLoS One. 10:117160. PubMed
  21. Kim Yu, et al. 2015. PLoS One. 10:120294. PubMed
  22. Hua X, et al. 2015. PloS One. 10:128039. PubMed
Product Citations
  1. Eger C, et al. 2016. PLoS One. 11: 0150479. PubMed
  2. Yang J, et al. 2016. Sci Rep. 6:38238. PubMed
  3. Chen T, et al. 2016. J Exp Med. 13(13):3025-3039. PubMed
  4. Martínez-Blanco Á, et al. 2021. Front Immunol. 12:713697. PubMed
  5. Wang H, et al. 2020. Mol Oncol. 14:991. PubMed
  6. Zhang Y, et al. 2017. Journal of Immunological Methods. 10.1016/j.taap.2017.05.020. PubMed
  7. Wu Y, et al. 2021. Immunity. 54:2595. PubMed
  8. Goel RR, et al. 2022. Cell. 185:1875. PubMed
  9. Campisi L, et al. 2022. Nature. 606:945. PubMed
  10. Grégoire C, et al. 2022. Immunity. 55:1216. PubMed
  11. Wu Y, et al. 2022. Sci Adv. 8:eabm7833. PubMed
  12. Cao Y, et al. 2023. Nature. 614:521. PubMed
  13. Weskamm LM, et al. 2022. STAR Protoc. 3:101902. PubMed
  14. Mekkaoui L, et al. 2023. Mol Ther Methods Clin Dev. 28:116. PubMed
  15. Lombard-Vadnais F, et al. 2023. iScience. 26:105852. PubMed
  16. Hernandez SPA, et al. 2023. Front Immunol. 13:1035344. PubMed
  17. Pušnik J, et al. 2023. Nat Commun. 14:572. PubMed
  18. Knyphausen P, et al. 2023. Nat Commun. 14:768. PubMed
  19. Yeh CH, et al. 2022. Immunity. 55:272. PubMed
  20. Feng J, et al. 2022. Immunity. 55:405. PubMed
  21. Tas JMJ, et al. 2022. Immunity. 55:1856. PubMed
  22. Melzi E, et al. 2022. Immunity. 55:2168. PubMed
  23. Vyasamneni R, et al. 2023. Cell Rep Methods. 3:100388. PubMed
  24. Ke F, et al. 2023. Elife. 12:. PubMed
  25. Li D, et al. 2023. Int J Oncol. 62:. PubMed
  26. Silva RP, et al. 2023. Elife. 12:. PubMed
  27. Nozuma S, et al. 2023. JCI Insight. 8:. PubMed
  28. García-Vega M, et al. 2023. iScience. 26:106562. PubMed
  29. Liu Y, et al. 2023. Nat Commun. 14:2179. PubMed
  30. Fathi M, et al. 2023. iScience. 26:106482. PubMed
  31. Xiao C, et al. 2023. Nat Aging. 3:418. PubMed
  32. Lv X, et al. 2023. Acta Pharm Sin B. 13:1631. PubMed
  33. Li X, et al. 2023. Nat Commun. 14:2929. PubMed
  34. Tundidor I, et al. 2023. Nat Commun. 14:3130. PubMed
  35. Chen K, et al. 2023. Gut Pathog. 15:28. PubMed
  36. Golubovskaya V, et al. 2023. Cancers (Basel). 15:. PubMed
  37. Tian L, et al. 2021. Int J Mol Sci. 22: . PubMed
  38. Lv X, et al. 2022. Acta Pharm Sin B. 12:735. PubMed
  39. Muliaditan T, et al. 2021. Cell Rep Med. 2:100457. PubMed
  40. Datta S, et al. 2014. J Leukoc Biol. 95:853. PubMed
  41. Larsen SB, et al. 2021. Cell Stem Cell. 28:1758. PubMed
  42. Delás MJ, et al. 2019. Cell Rep. 27:719. PubMed
  43. Viborg N, et al. 2019. Oncoimmunology. 8:e1663107. PubMed
  44. Yamakawa N, et al. 2012. Int Immunol. 25:45. PubMed
  45. Grevers L, et al. 2013. Ann Rheum Dis. 72:278. PubMed
  46. Gatineau J, et al. 2022. Front Immunol. 13:982839. PubMed
  47. Trendel N, et al. 2021. Sci Signal. 14:eaay9363. PubMed
  48. Biswas S, et al. 2021. Nature. 591:464. PubMed
  49. Wellner A, et al. 2021. Nat Chem Biol. 17:1057. PubMed
  50. Gniffke EP, et al. 2020. medRxiv. . PubMed
  51. Ruiz–Camp J, et al. 2019. EMBO Mol Med. 11:3. PubMed
  52. Nie X, et al. 2017. Cellular & Molecular Immunology. 10.1038/cmi.2017.17. PubMed
  53. Hernandez-Franco JF, et al. 2022. Front Immunol. 13:990900. PubMed
  54. Liang Q, et al. 2022. iScience. 25:104043. PubMed
  55. Xiao C, et al. 2022. iScience. 25:103934. PubMed
  56. Imbrechts M, et al. 2022. iScience. 25:104705. PubMed
  57. Kim Y, et al. 2015. PLoS One. 10:120294. PubMed
  58. Yamamoto K, et al. 2021. Cell Reports. 36(8):109576. PubMed
  59. Fukushima T, et al. 2019. Cell Rep. 29:4144. PubMed
  60. Ashbaugh J, et al. 2013. J Immunol. 190:4525. PubMed
  61. Hayatsu N et al. 2017. Immunity. 47(2):268-283 . PubMed
  62. Hu Y, et al. 2022. Nat Commun. 13:5313. PubMed
  63. Im S, et al. 2016. Nature. 537:417-421. PubMed
  64. He X, et al. 2021. Emerg Microbes Infect. 10:1555. PubMed
  65. Nishimoto K, et al. 2008. J Immunol. 181:4010. PubMed
  66. Cao Y, et al. 2022. Nature. :. PubMed
  67. Tsukamoto H, et al. 2013. Biochem Biophys Res Commun. 440:31. PubMed
  68. Phiwpan K, et al. 2015. PLoS One. 10:128198. PubMed
  69. Weiß S, et al. 2020. J Infect Dis. 222:1629. PubMed
  70. Schanda N, et al. 2021. Cells. 10:. PubMed
  71. Lucas A, et al. 2015. PLoS One. 10:117160. PubMed
  72. Köchl R, et al. 2020. Elife. 9:00. PubMed
  73. Niki T, et al. 2009. J Biol Chem. 284:32344. PubMed
  74. Ping Y, et al. 2020. Front Cell Dev Biol. 0.890972222. PubMed
  75. Lv Z, et al. 2020. Oncoimmunology. 9:1747688. PubMed
  76. Pfenninger P, et al. 2022. Front Immunol. 13:777113. PubMed
  77. Kristensen NP, et al. 2022. J Clin Invest. 132:. PubMed
  78. Qiu C, et al. 2022. Front Immunol. 12:764949. PubMed
  79. Cao Y, et al. 2022. Nature. 602:657. PubMed
  80. Rogers BM, et al. 2021. J Exp Med. 218:. PubMed
  81. Weiß S, et al. 2020. medRxiv. . PubMed
  82. Morimoto A, et al. 2021. Nat Commun. 12:2136. PubMed
  83. Kim C, et al. 2019. Cell Rep. 29:2202. PubMed
  84. Hansen UK, et al. 2020. Front Immunol. 11:373. PubMed
  85. Reading J, et al. 2013. J Immunol. 190:4542. PubMed
  86. Dietmar Herndler‐Brandstetter et al. 2018. Immunity. 48(4):716-729 . PubMed
  87. Mei H, et al. 2021. J Hematol Oncol. 14:161. PubMed
  88. Repáraz D, et al. 2022. J Immunother Cancer. 10:. PubMed
  89. Tschismarov R, et al. 2021. JCI Insight. 6:. PubMed
  90. Richardson LS, et al. 2020. Lab Chip. 3.948611111. PubMed
  91. Hebbar N, et al. 2022. Nat Commun. 13:587. PubMed
  92. McWilliam H, et al. 2016. Nat Immunol. 17: 531-537. PubMed
  93. Zhang S, et al. 2016. Sci Transl Med. 8: 341ra77. PubMed
  94. Kacherovsky N, et al. 2019. Nat Biomed Eng. 0.66875. PubMed
  95. Van Gool F, et al. 2019. Immunity. 50:362. PubMed
  96. Mainini F, et al. 2015. PLoS One. 10: 0145403. PubMed
  97. Jiang Y, et al. 2021. Cell Death Differ. 28:3009. PubMed
  98. Woo S, et al. 2013. J Leukoc Biol. 93:363. PubMed
  99. Baccala R, et al. 2012. J Immunol. 189:5976. PubMed
  100. Delacher M, et al. 2020. Immunity. 52:295. PubMed
  101. Tsukamoto H, et al. 2017. FEBS Lett. 10.1002/1873-3468.12768. PubMed
  102. Parente-Pereira AC, et al. 2022. STAR Protoc. 3:101319. PubMed
  103. Baltierra-Uribe SL, et al. 2021. Eur J Immunol. 51:2641. PubMed
  104. Schoutrop E, et al. 2022. Oncoimmunology. 11:2093426. PubMed
  105. Günaydın G, et al. 2014. Vaccine. 32:470. PubMed
  106. Matt P, et al. 2015. PLoS One. 10: 0137474. PubMed
  107. Davis Z, et al. 2016. PLoS Pathog. 12: 1005421. PubMed
  108. Roewe J, et al. 2020. Nat Commun. 3.260416667. PubMed
  109. Carestia A, et al. 2019. Cell Rep. 28:896. PubMed
  110. Scatizzi J, et al. 2012. J Immunol. 188:3307. PubMed
  111. Tian B, et al. 2017. Front Immunol. 10.3389/fimmu.2017.00956. PubMed
  112. Schoofs T et al. 2019. Immunity. 50(6):1513-1529 . PubMed
  113. Guo C, et al. 2021. Cell Rep Med. 2:100448. PubMed
  114. Chen YL, et al. 2021. J Biol Chem. :101420. PubMed
  115. Zhong MC, et al. 2021. J Exp Med. 218:. PubMed
  116. Mudd PA, et al. 2022. Cell. 185:603. PubMed
  117. Morikawa M, et al. 2016. PLoS One. 11:e0163607. PubMed
  118. Gniffke EP, et al. 2020. J Infect Dis. 222:1965. PubMed
  119. Leung EYL, et al. 2020. Mol Ther Oncolytics. 16:289. PubMed
  120. Nowak W, et al. 2020. EBioMedicine. 50:290-305.. PubMed
  121. Matsuda T, et al. 2022. iScience. 25:105324. PubMed
  122. Kim SP, et al. 2022. Cancer Immunol Res. :OF1. PubMed
  123. Cheloha RW, et al. 2021. RSC chem biol. 2:1692. PubMed
  124. Okamoto Y, et al. 2021. J Cell Sci. 134:. PubMed
  125. Wang W, et al. 2014. Proc Natl Acad Sci U S A. 111:14466. PubMed
  126. Miyauchi K, et al. 2016. Nat Immunol. 17:1447-1458. PubMed
  127. Hoffmann J, et al. 2021. Nat Commun. 12:3964. PubMed
  128. Lu X, et al. 2019. Cell Rep. 28:472. PubMed
  129. Andersen TK, et al. 2019. NPJ Vaccines. 4:9. PubMed
  130. He X, et al. 2014. J Immunol. 193:1314. PubMed
  131. Kanno A, et al. 2013. Int Immunol. 25:413. PubMed
  132. Dan JM, et al. 2021. Science. :371. PubMed
  133. Leary N, et al. 2022. J Extracell Vesicles. 11:e12197. PubMed
  134. Murakami Y, et al. 2014. J Immunol. 193:5208. PubMed
  135. Mchedlidze T, et al. 2016. Mucosal Immunol. 10.1038/mi.2016.20. PubMed
  136. Walker MR, et al. 2022. Sci Adv. 8:eabj9513. PubMed
  137. Yang Zhou J, et al. 2022. Front Immunol. 13:898473. PubMed
  138. Deng J, et al. 2021. J Leukoc Biol. 110:1171. PubMed
  139. DanDan Huang, Lang Bao 2016. J Microbiol Immunol Infect. 49:859-865. PubMed
  140. Kurashima Y, et al. 2021. Nat Commun. 12:1067. PubMed
  141. Wells DK, et al. 2020. Cell. 183:818. PubMed
  142. Schürch CM, et al. 2020. Cell. 182:1341. PubMed
  143. Chappaz S, et al. 2010. J Immunol. 185:3514. PubMed
  144. Altman JB, et al. 2018. Health Sci Rep. 1:e74. PubMed
  145. Hirunwidchayarat W, et al. 2017. Biochem Biophys Res Commun. 10.1016/j.bbrc.2017.07.012. PubMed
  146. Wang EY, et al. 2022. Cell Rep Methods. 2:. PubMed
  147. Lyngaa R, et al. 2014. Clin Cancer Res. 20:1768. PubMed
  148. Tripathi S, et al. 2016. Proc Natl Acad Sci U S A. 113: 1555 - 1564. PubMed
  149. Ando Y, Oku T, Tsuji T 2016. PLoS One. 11: 0162208. PubMed
  150. Zheng Q, et al. 2017. Mol Oncol. 10.1002/1878-0261.12056. PubMed
  151. Pedersen NW, et al. 2019. Nat Commun. 10:837. PubMed
  152. Yang C, et al. 2019. Nat Commun. 10:3931. PubMed
  153. Xiao C, et al. 2021. STAR Protoc. 2:100789. PubMed
  154. Rodrigues KA, et al. 2021. Sci Adv. 7:eabj6538. PubMed
  155. Szeto C, et al. 2022. Nat Commun. 13:4951. PubMed
  156. Yoshikawa S, et al. 2016. Sci Rep. 6:18738. PubMed
  157. Shibui A, et al. 2011. Exp Parasitol. 129:318. PubMed
  158. Wirasinha RC, et al. 2021. J Exp Med. 218: . PubMed
  159. Du Z, et al. 2020. J Allergy Clin Immunol. . PubMed
  160. Lautz JD, et al. 2019. Sci Rep. 9:10890. PubMed
  161. Kenney M, et al. 2017. Journal of Immunological Methods. 10.1016/j.jim.2017.07.001. PubMed
  162. Holm JS, et al. 2022. Nat Commun. 13:1935. PubMed
  163. Eger C, et al. 2016. PLoS One. 11: 0150479. PubMed
  164. Yang J, et al. 2016. Sci Rep. 6:38238. PubMed
  165. Chen T, et al. 2016. J Exp Med. 13(13):3025-3039. PubMed
  166. Martínez-Blanco Á, et al. 2021. Front Immunol. 12:713697. PubMed
  167. Wang H, et al. 2020. Mol Oncol. 14:991. PubMed
  168. Zhang Y, et al. 2017. Journal of Immunological Methods. 10.1016/j.taap.2017.05.020. PubMed
  169. Wu Y, et al. 2021. Immunity. 54:2595. PubMed
  170. Goel RR, et al. 2022. Cell. 185:1875. PubMed
  171. Campisi L, et al. 2022. Nature. 606:945. PubMed
  172. Grégoire C, et al. 2022. Immunity. 55:1216. PubMed
  173. Wu Y, et al. 2022. Sci Adv. 8:eabm7833. PubMed
  174. Cao Y, et al. 2023. Nature. 614:521. PubMed
  175. Weskamm LM, et al. 2022. STAR Protoc. 3:101902. PubMed
  176. Mekkaoui L, et al. 2023. Mol Ther Methods Clin Dev. 28:116. PubMed
  177. Lombard-Vadnais F, et al. 2023. iScience. 26:105852. PubMed
  178. Hernandez SPA, et al. 2023. Front Immunol. 13:1035344. PubMed
  179. Pušnik J, et al. 2023. Nat Commun. 14:572. PubMed
  180. Knyphausen P, et al. 2023. Nat Commun. 14:768. PubMed
  181. Yeh CH, et al. 2022. Immunity. 55:272. PubMed
  182. Feng J, et al. 2022. Immunity. 55:405. PubMed
  183. Tas JMJ, et al. 2022. Immunity. 55:1856. PubMed
  184. Melzi E, et al. 2022. Immunity. 55:2168. PubMed
  185. Vyasamneni R, et al. 2023. Cell Rep Methods. 3:100388. PubMed
  186. Ke F, et al. 2023. Elife. 12:. PubMed
  187. Li D, et al. 2023. Int J Oncol. 62:. PubMed
  188. Silva RP, et al. 2023. Elife. 12:. PubMed
  189. Nozuma S, et al. 2023. JCI Insight. 8:. PubMed
  190. García-Vega M, et al. 2023. iScience. 26:106562. PubMed
  191. Liu Y, et al. 2023. Nat Commun. 14:2179. PubMed
  192. Fathi M, et al. 2023. iScience. 26:106482. PubMed
  193. Xiao C, et al. 2023. Nat Aging. 3:418. PubMed
  194. Lv X, et al. 2023. Acta Pharm Sin B. 13:1631. PubMed
  195. Li X, et al. 2023. Nat Commun. 14:2929. PubMed
  196. Tundidor I, et al. 2023. Nat Commun. 14:3130. PubMed
  197. Chen K, et al. 2023. Gut Pathog. 15:28. PubMed
  198. Golubovskaya V, et al. 2023. Cancers (Basel). 15:. PubMed
  199. Tian L, et al. 2021. Int J Mol Sci. 22: . PubMed
  200. Lv X, et al. 2022. Acta Pharm Sin B. 12:735. PubMed
  201. Muliaditan T, et al. 2021. Cell Rep Med. 2:100457. PubMed
  202. Datta S, et al. 2014. J Leukoc Biol. 95:853. PubMed
  203. Larsen SB, et al. 2021. Cell Stem Cell. 28:1758. PubMed
  204. Delás MJ, et al. 2019. Cell Rep. 27:719. PubMed
  205. Viborg N, et al. 2019. Oncoimmunology. 8:e1663107. PubMed
  206. Yamakawa N, et al. 2012. Int Immunol. 25:45. PubMed
  207. Grevers L, et al. 2013. Ann Rheum Dis. 72:278. PubMed
  208. Gatineau J, et al. 2022. Front Immunol. 13:982839. PubMed
  209. Trendel N, et al. 2021. Sci Signal. 14:eaay9363. PubMed
  210. Biswas S, et al. 2021. Nature. 591:464. PubMed
  211. Wellner A, et al. 2021. Nat Chem Biol. 17:1057. PubMed
  212. Gniffke EP, et al. 2020. medRxiv. . PubMed
  213. Ruiz–Camp J, et al. 2019. EMBO Mol Med. 11:3. PubMed
  214. Nie X, et al. 2017. Cellular & Molecular Immunology. 10.1038/cmi.2017.17. PubMed
  215. Hernandez-Franco JF, et al. 2022. Front Immunol. 13:990900. PubMed
  216. Liang Q, et al. 2022. iScience. 25:104043. PubMed
  217. Xiao C, et al. 2022. iScience. 25:103934. PubMed
  218. Imbrechts M, et al. 2022. iScience. 25:104705. PubMed
  219. Kim Y, et al. 2015. PLoS One. 10:120294. PubMed
  220. Yamamoto K, et al. 2021. Cell Reports. 36(8):109576. PubMed
  221. Fukushima T, et al. 2019. Cell Rep. 29:4144. PubMed
  222. Ashbaugh J, et al. 2013. J Immunol. 190:4525. PubMed
  223. Hayatsu N et al. 2017. Immunity. 47(2):268-283 . PubMed
  224. Hu Y, et al. 2022. Nat Commun. 13:5313. PubMed
  225. Im S, et al. 2016. Nature. 537:417-421. PubMed
  226. He X, et al. 2021. Emerg Microbes Infect. 10:1555. PubMed
  227. Nishimoto K, et al. 2008. J Immunol. 181:4010. PubMed
  228. Cao Y, et al. 2022. Nature. :. PubMed
  229. Tsukamoto H, et al. 2013. Biochem Biophys Res Commun. 440:31. PubMed
  230. Phiwpan K, et al. 2015. PLoS One. 10:128198. PubMed
  231. Weiß S, et al. 2020. J Infect Dis. 222:1629. PubMed
  232. Schanda N, et al. 2021. Cells. 10:. PubMed
  233. Lucas A, et al. 2015. PLoS One. 10:117160. PubMed
  234. Köchl R, et al. 2020. Elife. 9:00. PubMed
  235. Niki T, et al. 2009. J Biol Chem. 284:32344. PubMed
  236. Ping Y, et al. 2020. Front Cell Dev Biol. 0.890972222. PubMed
  237. Lv Z, et al. 2020. Oncoimmunology. 9:1747688. PubMed
  238. Pfenninger P, et al. 2022. Front Immunol. 13:777113. PubMed
  239. Kristensen NP, et al. 2022. J Clin Invest. 132:. PubMed
  240. Qiu C, et al. 2022. Front Immunol. 12:764949. PubMed
  241. Cao Y, et al. 2022. Nature. 602:657. PubMed
  242. Rogers BM, et al. 2021. J Exp Med. 218:. PubMed
  243. Weiß S, et al. 2020. medRxiv. . PubMed
  244. Morimoto A, et al. 2021. Nat Commun. 12:2136. PubMed
  245. Kim C, et al. 2019. Cell Rep. 29:2202. PubMed
  246. Hansen UK, et al. 2020. Front Immunol. 11:373. PubMed
  247. Reading J, et al. 2013. J Immunol. 190:4542. PubMed
  248. Dietmar Herndler‐Brandstetter et al. 2018. Immunity. 48(4):716-729 . PubMed
  249. Mei H, et al. 2021. J Hematol Oncol. 14:161. PubMed
  250. Repáraz D, et al. 2022. J Immunother Cancer. 10:. PubMed
  251. Tschismarov R, et al. 2021. JCI Insight. 6:. PubMed
  252. Richardson LS, et al. 2020. Lab Chip. 3.948611111. PubMed
  253. Hebbar N, et al. 2022. Nat Commun. 13:587. PubMed
  254. McWilliam H, et al. 2016. Nat Immunol. 17: 531-537. PubMed
  255. Zhang S, et al. 2016. Sci Transl Med. 8: 341ra77. PubMed
  256. Kacherovsky N, et al. 2019. Nat Biomed Eng. 0.66875. PubMed
  257. Van Gool F, et al. 2019. Immunity. 50:362. PubMed
  258. Mainini F, et al. 2015. PLoS One. 10: 0145403. PubMed
  259. Jiang Y, et al. 2021. Cell Death Differ. 28:3009. PubMed
  260. Woo S, et al. 2013. J Leukoc Biol. 93:363. PubMed
  261. Baccala R, et al. 2012. J Immunol. 189:5976. PubMed
  262. Delacher M, et al. 2020. Immunity. 52:295. PubMed
  263. Tsukamoto H, et al. 2017. FEBS Lett. 10.1002/1873-3468.12768. PubMed
  264. Parente-Pereira AC, et al. 2022. STAR Protoc. 3:101319. PubMed
  265. Baltierra-Uribe SL, et al. 2021. Eur J Immunol. 51:2641. PubMed
  266. Schoutrop E, et al. 2022. Oncoimmunology. 11:2093426. PubMed
  267. Günaydın G, et al. 2014. Vaccine. 32:470. PubMed
  268. Matt P, et al. 2015. PLoS One. 10: 0137474. PubMed
  269. Davis Z, et al. 2016. PLoS Pathog. 12: 1005421. PubMed
  270. Roewe J, et al. 2020. Nat Commun. 3.260416667. PubMed
  271. Carestia A, et al. 2019. Cell Rep. 28:896. PubMed
  272. Scatizzi J, et al. 2012. J Immunol. 188:3307. PubMed
  273. Tian B, et al. 2017. Front Immunol. 10.3389/fimmu.2017.00956. PubMed
  274. Schoofs T et al. 2019. Immunity. 50(6):1513-1529 . PubMed
  275. Guo C, et al. 2021. Cell Rep Med. 2:100448. PubMed
  276. Chen YL, et al. 2021. J Biol Chem. :101420. PubMed
  277. Zhong MC, et al. 2021. J Exp Med. 218:. PubMed
  278. Mudd PA, et al. 2022. Cell. 185:603. PubMed
  279. Morikawa M, et al. 2016. PLoS One. 11:e0163607. PubMed
  280. Gniffke EP, et al. 2020. J Infect Dis. 222:1965. PubMed
  281. Leung EYL, et al. 2020. Mol Ther Oncolytics. 16:289. PubMed
  282. Nowak W, et al. 2020. EBioMedicine. 50:290-305.. PubMed
  283. Matsuda T, et al. 2022. iScience. 25:105324. PubMed
  284. Kim SP, et al. 2022. Cancer Immunol Res. :OF1. PubMed
  285. Cheloha RW, et al. 2021. RSC chem biol. 2:1692. PubMed
  286. Okamoto Y, et al. 2021. J Cell Sci. 134:. PubMed
  287. Wang W, et al. 2014. Proc Natl Acad Sci U S A. 111:14466. PubMed
  288. Miyauchi K, et al. 2016. Nat Immunol. 17:1447-1458. PubMed
  289. Hoffmann J, et al. 2021. Nat Commun. 12:3964. PubMed
  290. Lu X, et al. 2019. Cell Rep. 28:472. PubMed
  291. Andersen TK, et al. 2019. NPJ Vaccines. 4:9. PubMed
  292. He X, et al. 2014. J Immunol. 193:1314. PubMed
  293. Kanno A, et al. 2013. Int Immunol. 25:413. PubMed
  294. Dan JM, et al. 2021. Science. :371. PubMed
  295. Leary N, et al. 2022. J Extracell Vesicles. 11:e12197. PubMed
  296. Murakami Y, et al. 2014. J Immunol. 193:5208. PubMed
  297. Mchedlidze T, et al. 2016. Mucosal Immunol. 10.1038/mi.2016.20. PubMed
  298. Walker MR, et al. 2022. Sci Adv. 8:eabj9513. PubMed
  299. Yang Zhou J, et al. 2022. Front Immunol. 13:898473. PubMed
  300. Deng J, et al. 2021. J Leukoc Biol. 110:1171. PubMed
  301. DanDan Huang, Lang Bao 2016. J Microbiol Immunol Infect. 49:859-865. PubMed
  302. Kurashima Y, et al. 2021. Nat Commun. 12:1067. PubMed
  303. Wells DK, et al. 2020. Cell. 183:818. PubMed
  304. Schürch CM, et al. 2020. Cell. 182:1341. PubMed
  305. Chappaz S, et al. 2010. J Immunol. 185:3514. PubMed
  306. Altman JB, et al. 2018. Health Sci Rep. 1:e74. PubMed
  307. Hirunwidchayarat W, et al. 2017. Biochem Biophys Res Commun. 10.1016/j.bbrc.2017.07.012. PubMed
  308. Wang EY, et al. 2022. Cell Rep Methods. 2:. PubMed
  309. Lyngaa R, et al. 2014. Clin Cancer Res. 20:1768. PubMed
  310. Tripathi S, et al. 2016. Proc Natl Acad Sci U S A. 113: 1555 - 1564. PubMed
  311. Ando Y, Oku T, Tsuji T 2016. PLoS One. 11: 0162208. PubMed
  312. Zheng Q, et al. 2017. Mol Oncol. 10.1002/1878-0261.12056. PubMed
  313. Pedersen NW, et al. 2019. Nat Commun. 10:837. PubMed
  314. Yang C, et al. 2019. Nat Commun. 10:3931. PubMed
  315. Xiao C, et al. 2021. STAR Protoc. 2:100789. PubMed
  316. Rodrigues KA, et al. 2021. Sci Adv. 7:eabj6538. PubMed
  317. Szeto C, et al. 2022. Nat Commun. 13:4951. PubMed
  318. Yoshikawa S, et al. 2016. Sci Rep. 6:18738. PubMed
  319. Shibui A, et al. 2011. Exp Parasitol. 129:318. PubMed
  320. Wirasinha RC, et al. 2021. J Exp Med. 218: . PubMed
  321. Du Z, et al. 2020. J Allergy Clin Immunol. . PubMed
  322. Lautz JD, et al. 2019. Sci Rep. 9:10890. PubMed
  323. Kenney M, et al. 2017. Journal of Immunological Methods. 10.1016/j.jim.2017.07.001. PubMed
  324. Holm JS, et al. 2022. Nat Commun. 13:1935. PubMed

Related FAQs

What type of PE do you use in your conjugates?
We use R-PE in our conjugates.
Go To Top Version: 6    Revision Date: 06/17/2019

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account